This week we look at the need for advanced technology to drive productivity, crisis management and the direct relation to company reputation, sharing of research and development, marketing strategies for different countries and the pharmaceutical muscle needed for managing China’s large diabetes population
58% of Life Sciences companies continue to struggle with Excel spread sheets and multiple point solutions. Eye for Pharma’s The Role of Technology in Driving Productivity and Harnessing Lost Revenue emphasizes that pharmaceutical companies need to take advantage of advanced technologies to improve employee productivity and direct it toward maximizing revenue and profit performance
Research indicates that 63% of an organization’s market value is attributed to reputation, and protecting that reputation is no longer limited to shaping the traditional media environment. PharmaExec’s Crisis Preparedness in an Always-On Digital World discusses how a crisis can affect the pharmaceutical industry and how experts agree the most important factor is the timeliness and quality of response
Forbes’s Contributor, John LaMattina, states that no matter how big your R & D budget is, there is no way a single Pharma company can corner the market on great ideas. Should Pharma Companies Give Up Discovery Research? investigates the challenges of pharmaceutical research and development
Healthcare systems vary in the US, UK, Germany and Poland and according to Pharmaphorum this impacts pharmaceutical companies and how they market their products. Different Healthcare Systems Influence Marketing Practices by Pharmaceutical Companies compares the healthcare systems and shows the variation in marketing practices
China, as described by Pharma Daily, is a pharmaceutical firm’s dream market. Why is Big Pharma So Interested in China? Just Look At These Scary Diabetes Numbers provides information on this market and quotes a study in the Journal of American Medicine which estimates that about 11.6% of adults in mainland China suffer from diabetes, which equates to 114 million people
That wraps this week’s review of news from and for the pharma insight community. I’ll leave you with an invitation to learn more about the benefits of real time data and offer you a personal demo of InCrowd’s on-demand platform providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.
If you have tips, suggestions or resources you’d like to share leave us a note below and please feel free to suggest topics that you’d like to see covered in future posts.
